You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mocetinostat

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma Trial in New York (Mocetinostat Plus Brentuximab Vedotin)

Completed
Has Results
  • Hodgkin Lymphoma
  • Mocetinostat Plus Brentuximab Vedotin
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 10, 2022

Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)

Recruiting
  • Rhabdomyosarcoma
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 13, 2022

Lymphoma, Relapsed and Refractory, DLBCL and Follicular Lymphoma Trial in New York (Mocetinostat)

Active, not recruiting
  • Lymphoma
  • +2 more
  • Mocetinostat
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 17, 2021

Advanced Cancer Trial in United States (Mocetinostat - 50 mg, Mocetinostat - 70 mg, Mocetinostat - 90 mg)

Terminated
Has Results
  • Advanced Cancer
  • Mocetinostat - 50 mg
  • +4 more
  • Mobile, Alabama
  • +14 more
Mar 10, 2021

Melanoma Trial in New York (Mocetinostat Induction Phase + Ipilimumab + Nivolumab, Mocetinostat Maintenance Phase + Ipilimumab +

Terminated
  • Melanoma
  • Mocetinostat Induction Phase + Ipilimumab + Nivolumab
  • Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab
  • New York, New York
    New York University School of Medicine
May 19, 2020

Metastatic Leiomyosarcoma Trial in United States (Mocetinostat, Gemcitabine)

Completed
Has Results
  • Metastatic Leiomyosarcoma
  • Boston, Massachusetts
  • +4 more
Jan 4, 2019

Squamous Cell Carcinoma, Head And Neck, Squamous Cell Carcinoma Mouth, Resectable Squamous Cell Carcinoma of Oral Cavity Trial

Withdrawn
  • Squamous Cell Carcinoma, Head And Neck
  • +2 more
  • Mocetinostat
  • Durvalumab
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 27, 2017

Myelodysplastic Syndrome Trial in United States (Mocetinostat, Azacitidine)

Completed
  • Myelodysplastic Syndrome
  • Washington, D.C., District of Columbia
  • +9 more
Sep 6, 2017

Urothelial Carcinoma Trial in United States (Mocetinostat)

Completed
  • Urothelial Carcinoma
  • Mocetinostat
  • Birmingham, Alabama
  • +13 more
Aug 30, 2017

Hodgkin's Lymphoma Trial in Canada, United States (MGCD0103)

Terminated
  • Hodgkin's Lymphoma
  • Chicago, Illinois
  • +4 more
Jun 5, 2015

Lymphoma Trial in Canada, United States (MGCD0103)

Completed
  • Lymphoma
  • Durham, North Carolina
  • +4 more
Jun 4, 2015

Tumors Trial in Canada, United States (MGCD0103, Gemcitabine)

Completed
  • Tumors
  • Indianapolis, Indiana
  • +7 more
Jun 4, 2015

Lymphocytic Leukemia, Chronic Trial in Canada, United States (MGCD0103)

Completed
  • Lymphocytic Leukemia, Chronic
  • Kansas City, Missouri
  • +12 more
Jun 4, 2015

Myelogenous Leukemia, Acute, MDS Trial in Canada, United States (MGCD0103)

Terminated
  • Myelogenous Leukemia, Acute
  • Myelodysplastic Syndromes
  • Kansas City, Missouri
  • +12 more
Jun 4, 2015

Hodgkin Lymphoma, Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma) Trial in United

Terminated
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)
  • MGCD0103 and Azacitidine
  • Beech Grove, Indiana
  • +3 more
Jun 4, 2015

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)

Completed
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +7 more
Jun 4, 2015

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Canada, United Kingdom, United States (Azacitidine,

Terminated
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Houston, Texas
  • +7 more
Apr 22, 2015

Leukemia, MDS Trial in Houston, Toronto, Montreal (MGCD0103)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Houston, Texas
  • +2 more
Jan 6, 2015

Tumors, Non Hodgkin's Lymphoma Trial in Baltimore, Toronto, Greenfield Park (MGCD0103)

Completed
  • Tumors
  • Non Hodgkin's Lymphoma
  • Baltimore, Maryland
  • +2 more
Jan 6, 2015

Leukemia, MDS Trial in Canada, United States (MGCD0103)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +3 more
Jan 6, 2015

Breast Cancer, Lung Cancer, Pulmonary Cancer Trial in Baltimore, Philadelphia (MGCD0103 & Docetaxel)

Terminated
  • Breast Cancer
  • +7 more
  • MGCD0103 & Docetaxel
  • Baltimore, Maryland
  • +1 more
Jan 6, 2015